The Surveillance of Hepatocellular Carcinoma

The Surveillance of Development and Progression of Hepatocellular Carcinoma

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05286099

Enrollment

100

Registered

2022-03-18

Start date

2022-01-15

Completion date

2023-12-31

Last updated

2022-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

Early detection of hepatocellular carcinoma is vita to the prognosis of patient. In this study, the occurrence and development of liver cancer were supervised by imaging examination, and the dysplastic nodules will be distinguished from early hepatocellular carcinoma through macro-imaging and micro-pathological features.

Interventions

OTHERImaging examination and/or blood test

Imaging examination and/or blood test will be performed at a certain time

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

\- Patients with Hepatitis B and cirrhosis Accept regular imaging examination. Pathological diagnosis of liver cancer.

Exclusion criteria

\- Can't tolerate the enhanced imaging examination Poor medical compliance

Design outcomes

Primary

Measure	Time frame	Description
Effective detection of early hepatocellular carcinoma	2 years	The occurrence of early hepatocellular carcinoma

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026